<DOC>
	<DOCNO>NCT00468754</DOCNO>
	<brief_summary>This trial compare metabolic control type 1 diabetes obtain continuous infusion insulin lispro obtain multiple daily injection insulin lispro glargine , long-acting insulin analogue . Patients switch alternative treatment 4 month . Glucose variability last month treatment analyze .</brief_summary>
	<brief_title>A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro Glargine</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Type 1 diabetic patient , 1860 year age Diabetic &gt; 2 year Treated CSII &gt; =6 month HbA1c &lt; 8.5 % Treatment daily insulin injection Inability handle pump therapy Untreated retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>